IDEXX Laboratories, Inc. IDXX

519.26 5.87 1.14% as of 25 Sep
Market cap
$40.2B
P/E
36.2×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

IDEXX Laboratories, Inc. (IDXX) P/S ratio

As of 25 September 2026, IDEXX Laboratories, Inc. (IDXX) trades at a P/S ratio of 9.0×. Over the past ten years it has ranged from 3.7× (January 2016) to 19.8× (August 2021); the current reading is higher than 39% of that period. That is above the Diagnostics & Research industry median of 4.9× and above the Healthcare sector median of 3.8×.

P/S ratio, daily

Annual

Period P/S ratio Change
FY2025 12.6× 44.52%
FY2024 8.7× (29.61%)
FY2023 12.4× 23.25%
FY2022 10.1× (42.21%)
FY2021 17.4× 10.70%
FY2020 15.8× 68.70%
FY2019 9.3× 27.97%
FY2018 7.3× 3.79%
FY2017 7.0× 18.35%
FY2016 5.9× 41.00%

Quarterly

Period P/S ratio Change
Jun 2026 9.1× (9.31%)
Mar 2026 10.1× (20.38%)
Dec 2025 12.6× 2.96%
Sep 2025 12.3× 14.96%
42 more quarters

Against its own ten years

Low 3.7× High 19.8×
Ten-year median 9.8×
Current reading's percentile 39

P/S ratio against peers

Company P/S ratio
DGX Quest Diagnostics Incorporated compare 2.3×
IQV IQVIA Holdings Inc. compare 2.6×
A Agilent Technologies, Inc. compare 6.6×
MTD Mettler-Toledo International, Inc. compare 7.4×
IDXX IDEXX Laboratories, Inc. 9.0×
ILMN Illumina, Inc. compare 9.2×
WAT Waters Corporation compare 9.2×
GH Guardant Health, Inc. compare 19.9×
NTRA Natera, Inc. compare 21.8×
Diagnostics & Research industry median 4.9×
Healthcare sector median 3.8×
Market median 2.0×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on IDXX